Advancing Tomorrow’s Healthcare

About

CMAX is one of Australia’s largest and most experienced early phase clinical trial units. Centrally positioned in Adelaide, South Australia, CMAX is located opposite the Royal Adelaide Hospital and adjacent to the innovative Adelaide BioMed City precinct.

As Australia’s longest-operating early phase unit, CMAX conducts successful world-leading research for local and international clients, specialising in a range of early-phase trials and first-time-in-human studies (FTIH).

The team is proud that trials undertaken at CMAX have resulted in the advancement of global medicines and technologies, from cancer treatment and pain control to early warning bio-devices and hormone replacement therapies.

WHO WE ARE

cmax-values

ADVANCING TOMORROW’S HEALTH CARE

Meet the Team

Jane Kelly

Chief Executive Officer

Commencing her career as a registered nurse, Jane Kelly was a member of the CMAX foundation team and has worked with the organisation for more than two decades.

Jane has led the CMAX business, managing hundreds of trials for local and global pharmaceutical companies, as well as partnering with government and local health industries, to provide the best standards in clinical trials practice.

"We hold ourselves to the highest standards, working with our government and industry partners to benefit the health outcomes of communities worldwide." Jane Kelly, CEO.

nick-lee

Nick Lee

Chief Financial Officer

Lachlan-Ophof

Lachlan Ophof

Chief Operations Officer

zoe-harrison

Zoe Harrison

Chief Business Development Officer

Professor_Sepehr_Shakib_Cmax_web

Sepehr Shakib

Consulting Medical Director

Emir-REDZEPAGIC

Emir Redzepagic

Chief Research Physician

Alison-Barry

Alison Barry

Chief Quality Officer

Marianne-Horwood

Marianne Horwood

Clinical Services Director

Marina-Kuzmanov

Marina Kuzmanov

Proposals Manager

Miao-He

Miao He

Finance Manager

web_cmax_headhsots_2018_ (13)

Kate Beard

Study Start-up Manager

Kerie_Chalker_Cmax_web

Kerie Chalker

Human Resources Manager

CMAX_Chris_print smaller

Chris Holmes

Training Manager

Liliana_Zedda_Cmax_web

Liliana Zedda

Laboratory Manager

Picture1

Marketing and Engagement Lead

web__cmax_headhsots_c_itel_photography_201820180424_3

CTMS Project Lead

Angus-Suttor

Angus Suttor

Facility Services Manager

Dee-David

Dee David

Clinical Services Manager

Caroline Russo

Caroline Russo

Clinical Educator

Katherine Mudge

Clinical Project Team Lead

CMAX_Briohny_print smaller

Briohny Johnston

Senior Clinical Project Manager

Susan_Lee_Cmax_web

Su-san Lee

Senior Clinical Project Manager

Vicki_Ingleson_web

Victoria Ingleson

Senior Clinical Project Manager

CMAX_Francesca_print

Clinical Project Manager

CMAX_Kelly_print smaller

Kelly Harris

Clinical Project Manager

Manasi-Jambhrunker

Manasi Jambhrunker

Clinical Project Manager

chloe-douglas

Chloe Douglas

Clinical Project Manager

Sarada-Radha

Sarada Radha

Clinical Project Manager

Sanuja-Fernando

Sanuja Fernando

Clinical Project Manager

Nerissa-Lakhan

Nerissa Lakhan

Clinical Project Associate

Jessica-Micarone

Jessica Micarone

Clinical Project Associate

Board of directors

CMAX Clinical Research is a member of the I’rom Group, which is headquartered in Tokyo, Japan.

Based on our company philosophy, "Moving forward with the goal of building tomorrow’s healthcare", I'rom Group contributes to medical development with four businesses; Advanced Medicinal Treatment Services, Site Management Organization (SMO) Services, Contract Research Organization (CRO) Services, and Medical Support Services. I'rom Group continues to advance, with the strong belief that making new therapeutic technologies available to patients will give them hope for the future.

The CMAX Board of Directors bring with them a wealth of expertise from within research and commercial organisations to oversee the direction and management of the company.

  • Mr Toyotaka Mori, Chairman
  • Ms Jane Kelly, Director, Chief Executive Officer
  • Mr Tetsu Kawade, Director
  • Mr Colin Novick, Director
  • Mr Nicholas Lee, Company Secretary